Steven Van Laere

Associate Professor

University of Antwerp

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

LinkedIn ORCID Google Scholar Academic Page

About

Steven Van Laere is an Associate Professor at the University of Antwerp, Belgium. His research primarily focuses on inflammatory breast cancer, tumor immunology, and the molecular characterization of cancer progression. Recent publications include studies on macrophage polarization in breast cancer, the effects of co-targeting VEGFR2 and PD-L1 in mesothelioma, and the transcriptional changes associated with metabolic dysfunction in liver disease.

Steven Van Laere

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma

Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface

Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer

Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

Mutational landscape of inflammatory breast cancer

XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant

Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases

Maternal embryonic leucine zipper kinase is associated with metastasis in triple-negative breast cancer

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner

Obesity-associated changes in molecular biology of primary breast cancer

Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

L1CAM and laminin vascular network

OrBITS

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables

Collaborators (4)

Guy Van Camp

Wim Van Hul

Erik Fransen

Yolande Lievens

How do I reach out?

Meet Kite AI